Atrial fibrillation maintenance of rate control and sinus rhythm

Revision as of 13:34, 17 June 2009 by Swilliams (talk | contribs)
Jump to navigation Jump to search
Conduction
Sinus rhythm
Atrial fibrillation
Atrihttp://miles.wikidoc.org/skins/common/images/button_bold.pngal fibrillation
The P waves, which represent depolarization of the atria, are irregular or absent during atrial fibrillation.
ICD-10 I48
ICD-9 427.31
DiseasesDB 1065
MedlinePlus 000184
eMedicine med/184  emerg/46

WikiDoc Resources for Atrial fibrillation maintenance of rate control and sinus rhythm

Articles

Most recent articles on Atrial fibrillation maintenance of rate control and sinus rhythm

Most cited articles on Atrial fibrillation maintenance of rate control and sinus rhythm

Review articles on Atrial fibrillation maintenance of rate control and sinus rhythm

Articles on Atrial fibrillation maintenance of rate control and sinus rhythm in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Atrial fibrillation maintenance of rate control and sinus rhythm

Images of Atrial fibrillation maintenance of rate control and sinus rhythm

Photos of Atrial fibrillation maintenance of rate control and sinus rhythm

Podcasts & MP3s on Atrial fibrillation maintenance of rate control and sinus rhythm

Videos on Atrial fibrillation maintenance of rate control and sinus rhythm

Evidence Based Medicine

Cochrane Collaboration on Atrial fibrillation maintenance of rate control and sinus rhythm

Bandolier on Atrial fibrillation maintenance of rate control and sinus rhythm

TRIP on Atrial fibrillation maintenance of rate control and sinus rhythm

Clinical Trials

Ongoing Trials on Atrial fibrillation maintenance of rate control and sinus rhythm at Clinical Trials.gov

Trial results on Atrial fibrillation maintenance of rate control and sinus rhythm

Clinical Trials on Atrial fibrillation maintenance of rate control and sinus rhythm at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Atrial fibrillation maintenance of rate control and sinus rhythm

NICE Guidance on Atrial fibrillation maintenance of rate control and sinus rhythm

NHS PRODIGY Guidance

FDA on Atrial fibrillation maintenance of rate control and sinus rhythm

CDC on Atrial fibrillation maintenance of rate control and sinus rhythm

Books

Books on Atrial fibrillation maintenance of rate control and sinus rhythm

News

Atrial fibrillation maintenance of rate control and sinus rhythm in the news

Be alerted to news on Atrial fibrillation maintenance of rate control and sinus rhythm

News trends on Atrial fibrillation maintenance of rate control and sinus rhythm

Commentary

Blogs on Atrial fibrillation maintenance of rate control and sinus rhythm

Definitions

Definitions of Atrial fibrillation maintenance of rate control and sinus rhythm

Patient Resources / Community

Patient resources on Atrial fibrillation maintenance of rate control and sinus rhythm

Discussion groups on Atrial fibrillation maintenance of rate control and sinus rhythm

Patient Handouts on Atrial fibrillation maintenance of rate control and sinus rhythm

Directions to Hospitals Treating Atrial fibrillation maintenance of rate control and sinus rhythm

Risk calculators and risk factors for Atrial fibrillation maintenance of rate control and sinus rhythm

Healthcare Provider Resources

Symptoms of Atrial fibrillation maintenance of rate control and sinus rhythm

Causes & Risk Factors for Atrial fibrillation maintenance of rate control and sinus rhythm

Diagnostic studies for Atrial fibrillation maintenance of rate control and sinus rhythm

Treatment of Atrial fibrillation maintenance of rate control and sinus rhythm

Continuing Medical Education (CME)

CME Programs on Atrial fibrillation maintenance of rate control and sinus rhythm

International

Atrial fibrillation maintenance of rate control and sinus rhythm en Espanol

Atrial fibrillation maintenance of rate control and sinus rhythm en Francais

Business

Atrial fibrillation maintenance of rate control and sinus rhythm in the Marketplace

Patents on Atrial fibrillation maintenance of rate control and sinus rhythm

Experimental / Informatics

List of terms related to Atrial fibrillation maintenance of rate control and sinus rhythm

Cardiology Network

Discuss Atrial fibrillation maintenance of rate control and sinus rhythm further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Synonyms and related keywords: AF, Afib, fib

Overview

ACC / AHA Guidelines- Maintenance of Sinus Rhythm (DO NOT EDIT) [1]

Class I

1. Before initiating antiarrhythmic drug therapy, treatment of precipitating or reversible causes of AF is recommended. (Level of Evidence: C)

Class IIa

1. Pharmacological therapy can be useful in patients with AF to maintain sinus rhythm and prevent tachycardia induced cardiomyopathy. (Level of Evidence: C)

2. Infrequent, well-tolerated recurrence of AF is reasonable as a successful outcome of antiarrhythmic drug therapy. (Level of Evidence: C)

3. Outpatient initiation of antiarrhythmic drug therapy is reasonable in patients with AF who have no associated heart disease when the agent is well tolerated. (Level of Evidence: C)

4. In patients with lone AF without structural heart disease, initiation of propafenone or flecainide can be beneficial on an outpatient basis in patients with paroxysmal AF who are in sinus rhythm at the time of drug initiation. (Level of Evidence: B)

5. Sotalol can be beneficial in outpatients in sinus rhythm with little or no heart disease, prone to paroxysmal AF, if the baseline uncorrected QT interval is less than 460 ms, serum electrolytes are normal, and risk factors associated with class III drug–related pro-arrhythmia are not present. (Level of Evidence: C)

6. Catheter ablation is a reasonable alternative to pharmacological therapy to prevent recurrent AF in symptomatic patients with little or no LA enlargement. (Level of Evidence: C)

Class III

1. Antiarrhythmic therapy with a particular drug is not recommended for maintenance of sinus rhythm in patients with AF who have well-defined risk factors for proarrhythmia with that agent. (Level of Evidence: A)

2. Pharmacological therapy is not recommended for maintenance of sinus rhythm in patients with advanced sinus node disease or AV node dysfunction unless they have a functioning electronic cardiac pacemaker. (Level of Evidence: C)

See Also

Sources

  • The ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation [1]

References

  1. 1.0 1.1 Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation- Executive Summary: executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidlines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006; 114: 700-752. PMID 16908781

Further Readings

  • Fuster V, Rydén LE, Cannom DS, et al (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation 114 (7): e257-354. doi:10.1161/CIRCULATIONAHA.106.177292. PMID 16908781.
  • Estes NAM 3rd, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS, McNamara RL, Messer JV, Ritchie JL, Romeo SJW, Waldo AL, Wyse DG. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with non valvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Performance Measures for Atrial Fibrillation). Circulation 2008; 117:1101–1120

Template:SIB

de:Vorhofflimmern it:Fibrillazione atriale nl:Boezemfibrilleren no:Atrieflimmer fi:Eteisvärinä


Template:WikiDoc Sources